Enfusion, Inc. (NYSE:ENFN – Get Rating) CTO Dan Groman sold 15,048 shares of the company’s stock in a transaction that occurred on Wednesday, May 10th. The stock was sold at an average price of $8.34, for a total value of $125,500.32. Following the sale, the chief technology officer now directly owns 79,809 shares of the […]
Enfusion (NYSE:ENFN – Get Rating) is scheduled to be issuing its quarterly earnings data before the market opens on Tuesday, May 9th. Analysts expect the company to announce earnings of $0.03 per share for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link. Enfusion (NYSE:ENFN – […]
Enfusion, Inc. (NYSE:ENFN – Get Rating) CTO Dan Groman sold 3,877 shares of the stock in a transaction dated Monday, April 17th. The stock was sold at an average price of $9.66, for a total transaction of $37,451.82. Following the sale, the chief technology officer now owns 82,102 shares of the company’s stock, valued at […]
Enfusion, Inc. (NYSE:ENFN – Get Rating) was the recipient of a significant decline in short interest in the month of March. As of March 31st, there was short interest totalling 1,280,000 shares, a decline of 9.2% from the March 15th total of 1,410,000 shares. Based on an average daily trading volume, of 399,900 shares, the […]
Enfusion, Inc. (NYSE:ENFN – Get Rating) CTO Dan Groman sold 3,877 shares of the stock in a transaction that occurred on Monday, April 17th. The shares were sold at an average price of $9.66, for a total transaction of $37,451.82. Following the completion of the transaction, the chief technology officer now owns 82,102 shares in […]